Interest groups seek to add goodies to fast-moving FDA overhaul bill-modernhealthcare: WASHINGTON – Why is the nation's capital suddenly obsessed with biomedical innovation?
And why is the fruit of that obsession, the proposed 21st Century Cures Act, moving like a freight train through the usually deadlocked congressional process—even though some experts warn it could undermine the Food and Drug Administration's ability to protect the public from unproven and potentially unsafe new drugs and medical devices?
